All News #Library
Biotech
Cyrano Therapeutics Announces Positive Phase 2 CYR-064 Results
17 Feb 2026 //
PR NEWSWIRE
Cyrano Launch Study on CYR-064 for Hyposmia in Parkinson’s Disease
04 Feb 2025 //
PR NEWSWIRE

Market Place
Sourcing Support